“Colonoscopy” trends with Twitter reactions to study

This weekend, a study out of Oslo, Norway, published in the New England Journal of Medicine questioned the effectiveness of colonoscopy in preventing colorectal cancer, the second deadliest cancer in the United States. The study triggered a swell of media reports casting doubt on the procedure.
It also inspired a lot of tweeting and more than a few threads of analysis by experts, many of them taking issue with the simple conclusions made by news headlines or the study itself.
The Colorectal Cancer Alliance’s CEO, Michael Sapienza, made our position clear on Twitter.
Numerous physicians and researchers, including Houston-based gastroenterologist Manreet Kaur, took issue with the study’s methodology, including:
Read the Alliance’s statement on this study here.
Share inspiring messages with a side of awareness by sending these Happy New Years cards to your friends and family!
Learn how the Colorectal Cancer Alliance is advocating for the passage of the Nancy Gardner Sewell Multi-Cancer Early Detection Act (HR 2407), a bipartisan bill that ensures immediate Medicare coverage for life-saving cancer detection tests once approved by the FDA.
The Alliance’s 45+ Reasons campaign is part of the Cycles of Impact initiative launched and supported by Independence Blue Cross in 2022 to address the urgent public health issue of colorectal cancer among the Black population.